LRRK2: a link between familial and sporadic Parkinson's disease?

Pathologie Biologie

Volumn 55, Issue 2, 2007, Pages 107-110

  Lesage, S ^a,b   Durr A ^a,b   Brice, A ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Autosomal dominant transmission; G2019S mutation; LRRK2; Monogenic forms; Neurodegenerative disorder; Parkinson's disease

Indexed keywords

GUANOSINE TRIPHOSPHATASE; LEUCINE RICH REPEAT KINASE 2; MESSENGER RNA; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

AUTOSOMAL DISORDER; COMPLEX FORMATION; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; EDITORIAL; EXON; FAMILIAL DISEASE; G2019S GENE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HETEROZYGOSITY; HUMAN; MOLECULAR INTERACTION; PARKINSON DISEASE; PHENOTYPE; PROTEIN DOMAIN; ADULT; AGED; AMINO ACID SUBSTITUTION; ANIMAL; CHEMISTRY; DOMINANT GENE; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETICS; MALE; MIDDLE AGED; MISSENSE MUTATION; MOUSE; ONSET AGE; PHYSIOLOGY; POINT MUTATION; PROTEIN TERTIARY STRUCTURE;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ANIMALS; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENES, DOMINANT; HUMANS; MALE; MICE; MIDDLE AGED; MUTATION, MISSENSE; PARKINSON DISEASE; PHENOTYPE; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES;

EID: 33947247929     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2006.06.001     Document Type: Editorial

References (45)

1. Elbaz A., Grigoletto F., Baldereschi M., Breteler M.M., Manubens-Bertran J.M., Lopez-Pousa S., et al. Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology 52 (1999) 1876-1882
2. Periquet M., Latouche M., Lohmann E., Rawal N., De Michele G., Ricard S., et al. Parkin mutations are frequent in patients with isolated early-onset Parkinsonism. Brain 126 (2003) 1271-1278
3. Lohmann E., Periquet M., Bonifati V., Wood N.W., De Michele G., Bonnet A.M., et al. How much phenotypic variation can be attributed to Parkin genotype?. Ann. Neurol. 54 (2003) 176-185
4. Abou-Sleiman P.M., Healy D.G., Quinn N., Lees A.J., and Wood N.W. The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann. Neurol. 54 (2003) 283-286
5. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset Parkinsonism. Science 299 (2003) 256-259
6. Hague S., Rogaeva E., Hernandez D., Gulick C., Singleton A., Hanson M., et al. Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann. Neurol. 54 (2003) 271-274
7. Ibanez P., De Michele G., Bonifati V., Lohmann E., Thobois S., Pollak P., et al. Screening for DJ-1 mutations in early onset autosomal recessive Parkinsonism. Neurology 61 (2003) 1429-1431
8. Hatano Y., Li Y., Sato K., Asakawa S., Yamamura Y., Tomiyama H., et al. Novel PINK1 mutations in early-onset Parkinsonism. Ann. Neurol. 56 (2004) 424-427
9. Healy D.G., Abou-Sleiman P.M., Gibson J.M., Ross O.A., Jain S., Gandhi S., et al. PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology 63 (2004) 1486-1488
10. Rohe C.F., Montagna P., Breedveld G., Cortelli P., Oostra B.A., and Bonifati V. Homozygous PINK1 C-terminus mutation causing early-onset Parkinsonism. Ann. Neurol. 56 (2004) 427-431
11. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 (2004) 1158-1160
12. Valente E.M., Salvi S., Ialongo T., Marongiu R., Elia A.E., Caputo V., et al. PINK1 mutations are associated with sporadic early-onset Parkinsonism. Ann. Neurol. 56 (2004) 336-341
13. Bonifati V., Rohe C.F., Breedveld G.J., Fabrizio E., De Mari M., Tassorelli C., et al. Early-onset Parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 65 (2005) 87-95
14. Klein C., Djarmati A., Hedrich K., Schafer N., Scaglione C., Marchese R., et al. PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset Parkinsonism. Eur. J. Hum. Genet. 13 (2005) 1086-1093
15. Ibáñez P., Lesage S., Lohmann E., Broussolle E., De Michele G., Borg M., et al. Mutational analysis of the PINK1 gene in early-onset Parkinsonism in Europe and North Africa. Brain 129 (2006) 686-694
16. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
17. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
18. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55 (2004) 164-173
19. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
20. Chartier-Harlin M.C., Kachergus J., Roumier C., Mouroux V., and Douay X. Lincoln S, et al. α-Synuclein duplication as a cause of familial Parkinson's disease. Lancet 364 (2004) 1167-1169
21. Ibanez P., Bonnet A.M., Debarges B., Lohmann E., Tison F., Pollak P., et al. Causal relation between α-synuclein gene duplication and familial Parkinson's disease. Lancet 364 (2004) 1169-1171
22. Nishioka K., Hayashi S., Farrer M.J., Singleton A.B., Yoshino H., Imai H., et al. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Ann. Neurol. 59 (2006) 298-309
23. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
24. Zimprich A., Biskup S., Leitner P., Lichtner P., and Farrer M. Lincoln et al. Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44 (2004) 601-607
25. Gloeckner C.J., Kinkl N., Schumacher A., Braun R.J., O'Neill E., Meitinger T., et al. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum. Mol. Genet. 15 (2006) 223-232
26. Smith W.W., Pei Z., Jiang H., Moore D.J., Liang Y., West A.B., et al. Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc. Natl. Acad. Sci. USA 102 (2005) 18676-18681
27. West A.B., Moore D.J., Biskup S., Bugayenko A., Smith W.W., Ross C.A., et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. USA 102 (2005) 16842-16847
28. Bosgraf L., and Van Haastert P.J. Roc, a Ras/GTPase domain in complex proteins. Biochim. Biophys. Acta 1643 (2003) 5-10
29. Di Fonzo A., Rohe C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365 (2005) 412-415
30. Nichols W.C., Pankratz N., Hernandez D., Paisan-Ruiz C., Jain S., Halter C.A., et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365 (2005) 410-412
31. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365 (2005) 415-416
32. Lu C.S., Simons E.J., Wu-Chou Y.H., Fonzo A.D., Chang H.C., Chen R.S., et al. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease. Parkinsonism Relat. Disord. 11 (2005) 521-522
33. Skipper L., Shen H., Chua E., Bonnard C., Kolatkar P., Tan L.C., et al. Analysis of LRRK2 functional domains in nondominant Parkinson disease. Neurology 65 (2005) 1319-1321
34. Tan E.K., Shen H., Tan L.C., Farrer M., Yew K., Chua E., et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci. Lett. 384 (2005) 327-329
35. Lesage S., Durr A., Tazir M., Lohmann E., Leutenegger A.L., Janin S., et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N. Engl. J. Med. 354 (2006) 422-423
36. Lesage S., Ibanez P., Lohmann E., Pollak P., Tison F., Tazir M., et al. G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann. Neurol. 58 (2005) 784-787
37. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 354 (2006) 424-425
38. Kachergus J., Mata I.F., Hulihan M., Taylor J.P., Lincoln S., Aasly J., et al. Identification of a novel LRRK2 mutation linked to autosomal dominant Parkinsonism: evidence of a common founder across European populations. Am. J. Hum. Genet. 76 (2005) 672-680
39. Lesage S., Janin S., Lohmann E., Leutenegger A.L., Viallet F., Pollak P., et al. LRRK2 exon 41 mutations in European sporadic Parkinson's disease. Arch. Neurol. (2006) (in press)
40. Lesage S., Leutenegger A.L., Ibanez P., Janin S., Lohmann E., Durr A., et al. LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century. Am. J. Hum. Genet. 77 (2005) 330-332
41. Kay D.M., Kramer P., Higgins D., Zabetian C.P., and Payami H. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation. Mov. Disord. 20 (2005) 1077-1078
42. Khan N.L., Jain S., Lynch J.M., Pavese N., Abou-Sleiman P., Holton J.L., et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 128 (2005) 2786-2796
43. Berg D., Schweitzer K., Leitner P., Zimprich A., Lichtner P., Belcredi P., et al. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*. Brain 128 (2005) 3000-3011
44. Ishihara L., Warren L., Gibson R., Amouri R., Lesage S., Dürr A., et al. Clinical features of Parkinson's disease patients homozygous for Lrrk2 G2019S. Arch. Neurol. (2006) (in press)
45. Korr D., Toschi L., Donner P., Pohlenz H.D., Kreft B., and Weiss B. LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain. Cell Signal 18 (2006) 910-920 (Epub 2005)